Symbol

OTLK Stock Financials and Fundamentals

Company Info

Company Full Name

Oncobiologics, Inc.

Full name of the company.

Industry Name

MEDICAL-BIOMED/GENETICS

Industry name

Major Industry Name

DRUGS

Major industry name

Sector Name

Medical

Sector name

Market Info

Current Price

$0.44

Current price of the stock

Trading Volume

$1M

Trading volume of the stock

Market Capitalization

$16.0M

Market capitalization of the company

Market Cap Category

Nano Cap

Category of market capitalization

Long-Term Growth Estimate

Long-term growth mean estimate

Analyst Rating Mean

3.71

Mean analyst rating

Potential Upside

1226.38%

Potential price appreciation based on analyst price targets

EPS Surprise Percentage Difference

4.35%

Percentage difference of EPS surprise

Dividends

Dividend Change (1 Year)

Dividend change over 1 year

Dividend Rate

$0.00

Shows the amount of dividend paid

Balance Sheet

Total Debt to Equity Ratio

-0.93

Total debt to total equity ratio

Current Ratio

0.38

Current ratio

Company Profitability

Gross Profit Margin

1098.52%

Gross profit margin

Operating Profit Margin

18863.91%

Operating profit margin

EBIT Margin

18863.90%

Earnings before interest and taxes (EBIT) margin

EBITDA Margin

Earnings before interest, taxes, depreciation, and amortization (EBITDA) margin

Pretax Profit Margin

16175.93%

Pretax profit margin

Net Profit Margin

14482.20%

Net profit margin

Return on Equity (ROE)

41.30%

Measures profitability relative to shareholders' equity

Return on Tangible Equity

41.30%

ROE excluding intangible assets

Return on Assets (ROA)

-71.53%

Measures profitability relative to total assets

Return on Invested Capital (ROIC)

41.30%

Measures profitability relative to invested capital

Management Effectiveness

Asset Turnover (quarterly)

-0.00

Asset turnover ratio

Inventory Turnover (quarterly)

0.27

Inventory turnover ratio

Receivables Turnover (quarterly)

-0.06

Receivables turnover ratio

Days Sales Outstanding

-1461.90

Average number of days it takes to collect receivables

Valuation Measures

Price-to-Earnings (P/E) Ratio

-0.26

Measures valuation relative to earnings

Forward P/E Ratio

P/E based on future earnings estimates

Price-to-Sales (P/S) Ratio

11.32

Measures valuation relative to sales

Price-to-Book (P/B) Ratio

-0.77

Measures valuation relative to book value

Price-to-Operating Cash Flow (P/OCF) Ratio

-0.12

Measures valuation relative to operating cash flow

Price-to-Free Cash Flow (P/FCF) Ratio

-0.12

Measures valuation relative to free cash flow

Cash Flow Statement

Net Acquisitions/Divestitures

Indicates company's M&A activity